RegSci Early Career Seminar

Please join us for our first RegSci Early Career Seminar co-hosted by the Harvard-MIT Center for Regulatory Science and the Therapeutics Graduate Program. At this event Dr. Sowmya Chary, Associate Medical Director at Biogen, will describe the role of regulatory science in industry, its involvement in all stages of drug development, and the vast roles that fall under the regulatory science umbrella. She will also discuss her training and career path that led to her current role at Biogen, as well as some tips and tricks for internships and networking. This event will be geared toward trainees (graduate and professional students), but all are welcome!

ABOUT DR. SOWMYA CHARY

Dr. Chary is currently an Associate Medical Director in Global Medical Safety within Global Safety and Regulatory Sciences at Biogen in Cambridge. Prior to this role, she was with Takeda Pharmaceutical Company in Cambridge as an Associate Medical Director in Global Patient Safety Evaluation. At Takeda, Dr. Chary worked in the Gastroenterology division on post-marketing safety surveillance of a biologic agent for the treatment of inflammatory bowel disease. During this time, she also served on the board of medical advisors for a Cambridge-based life science startup, CareTalk, where she led framework development for the clinical review of scientific content for publication on their platform.

Dr. Chary recently graduated from the Master of Medical Sciences in Clinical Investigation Program at HMS where she worked as a research trainee under the mentorship of Dr. Kenneth Christopher in the renal division at BWH. Her research area of interest and thesis focused on gender-specific critical illness metabolomics and metabolomic response to intervention. Prior to this, she also completed the Introduction to Clinical Research Training Program and Global Clinical Scholars Research Training Program offered through HMS. Dr. Chary completed her medical training in India and graduated with an MBBS from Sri Ramachandra Medical College and Research Institute.

WHAT IS REGULATORY SCIENCE?

Regulatory science comprises a range of scientific disciplines that are applied to the quality, safety and efficacy assessment of medicinal products and that inform regulatory decision-making throughout the lifecycle of a medicine.

ABOUT THE HARVARD-MIT CENTER FOR REGULATORY SCIENCE

The Harvard-MIT Center for Regulatory Science was formally launched in 2018 to advance research and education in regulatory science. The Center serves the broad community of biomedical research scientists and physicians in academia, industry, and regulatory agencies who seek to improve the development and evaluation of medical products. The Center is open to faculty and trainees from all institutions in the Boston area and aims to establish a three-way dialogue between academic medical research, drug development in biotechnology and pharmaceutical companies, and clinical care in the US and worldwide.

ABOUT THE HARVARD THERAPEUTICS GRADUATE PROGRAM

The Therapeutics Graduate Program focuses on pharmacology, toxicology and drug discovery, emphasizing research in both HMS labs and in real-world internships. Our goal is to provide students with the intellectual tool kit and practical skills necessary to be productive researchers in therapeutics discovery throughout the workforce. The certificate program offers rigorous, multidisciplinary training relevant to identifying and developing novel therapeutics, understanding and investigating mechanisms of drug action, analyzing the reasons for clinical failures, and developing new compounds and applying them in preclinical and clinical studies to improve the treatment of disease.